Skip to main content
CSPC Pharmaceutical Group Limited logo

CSPC Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 1093 ISIN · US12591J1088 LEI · 529900M3XQCW234H8O91 HKEX Manufacturing
Open in API
Filings indexed 1,518 across all filing types
Latest filing 2024-06-12 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 1093

About CSPC Pharmaceutical Group Limited

https://www.cspc.com.hk/en/global/home.…

CSPC Pharmaceutical Group Limited is a comprehensive enterprise specializing in the research, development, manufacturing, and sale of pharmaceutical products. The company operates across two main segments: finished drugs and bulk drugs. It emphasizes innovation and new drug development, evidenced by substantial R&D investment, to produce high-quality, effective, and reliable medicines. Its portfolio includes key innovative products such as NBP (soft capsules and injections), Oulaining, and Enxi, which are among its top-selling drugs.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME
Transaction in Own Shares Classification · 100% confidence The document is a voluntary announcement by CSPC Pharmaceutical Group Limited regarding the purchase of shares on the market pursuant to a share award scheme. It details the number of shares purchased, the average price, and the total consideration. There is no financial report, earnings data, or management discussion. The document is short (2308 characters) and serves as an announcement of a share purchase related to the company's share award scheme. This fits the category of Transaction in Own Shares (POS), which covers company buybacks or share purchases for schemes. It is not a report, regulatory filing, or other category.
2024-06-12 English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME
Transaction in Own Shares Classification · 95% confidence The document is a voluntary announcement by CSPC Pharmaceutical Group Limited regarding the purchase of shares on the market pursuant to a share award scheme. It details the number of shares purchased, the average consideration per share, and the total consideration. There is no indication of this being a full financial report, earnings release, or regulatory filing. The content specifically relates to the company's purchase of its own shares under a share award scheme, which fits the definition of a Transaction in Own Shares (POS). The document length is short and it is an announcement, not a report or certification, so it is not RPA or RNS. Therefore, the appropriate classification is POS.
2024-06-11 English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME
Transaction in Own Shares Classification · 100% confidence The document is a voluntary announcement by CSPC Pharmaceutical Group Limited regarding the purchase of shares on the market pursuant to a share award scheme. It details the number of shares purchased, the average price, and the balance of shares held by the trustee. There is no indication of financial results, management discussion, or regulatory filings beyond this specific transaction. The content clearly relates to the company buying back or purchasing its own shares for the share award scheme. The document length is short (2307 characters) and it is an announcement of a share purchase transaction, not a full financial report or other type of filing. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2024-06-07 English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME
Transaction in Own Shares Classification · 100% confidence The document is a voluntary announcement by CSPC Pharmaceutical Group Limited regarding the purchase of shares on the market pursuant to a share award scheme. It details the number of shares purchased, the average price, and the balance of shares held by the trustee. There is no financial report, earnings data, or management discussion. The document is short (2308 characters) and serves as an announcement of a share purchase related to the company's share award scheme. This fits the definition of a Transaction in Own Shares (POS) filing, which covers company buybacks or share purchases for schemes. Therefore, the appropriate classification is POS.
2024-06-04 English
VOLUNTARY ANNOUNCEMENT - PURCHASE OF SHARES ON-MARKET PURSUANT TO THE SHARE AWARD SCHEME
Transaction in Own Shares Classification · 95% confidence The document is a voluntary announcement regarding the purchase of shares on the market pursuant to a share award scheme. It details the number of shares purchased, the average price, and the total consideration. The document is relatively short (2308 characters) and focuses on a specific transaction related to the company's share repurchase for an employee share award scheme. It does not contain financial statements, earnings data, or management discussion. It is not an announcement of voting results, board changes, or legal matters. The content fits best with a report of the company buying back or selling its own shares, which corresponds to the 'Transaction in Own Shares' category (POS).
2024-06-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2024
Transaction in Own Shares Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 May 2024. It details movements in issued shares, share options, repurchases, and other share capital changes for CSPC Pharmaceutical Group Limited. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital movements and share repurchases. It does not contain financial statements, earnings data, management discussion, or audit information. It is a regulatory compliance filing focused on share capital changes and share repurchases. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares. The document is over 6000 characters and contains detailed data on share movements, not just an announcement or summary, so it is not a simple announcement (RPA) or regulatory filing (RNS).
2024-06-03 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.